U.S. Antitrust Investigation of Generics to Look into Two Dozen Drugs - Bloomberg
- Wall Street again marks new highs in post-election run
- Broadcom Ltd. (AVGO) Tops Q4 EPS by 11c
- Restoration Hardware (RH) Tops Q3 EPS by 4c; Guides Well Below the Street
- Unusual 11 Mid-Day Movers 12/8: (COOL) (TLRD) (DRAM) Higher; (SHIP) (OHRP) (MLSS) Lower
- After-Hours Stock Movers 12/08: (FNSR) (AVGO) (GLPG) Higher; (XTLY) (RH) (DLTH) Lower (more...)
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
(Updated - November 3, 2016 2:23 PM EDT)
U.S. prosecutors are "bearing down" on generic pharma companies in a sweeping criminal investigation into suspected price collusion, according to Bloomberg. The antitrust investigation by the DOJ spans more than a dozen companies and two dozen drugs, sources told the news service. A grand jury probe is examining some executives and the first charges could emerge by the end of the year.
Companies mentioned in the report include Mylan (NASDAQ: MYL), Allergan (NYSE: AGN) and Teva Pharma (NYSE: TEVA), Lannett (NYSE: LCI), Impax Laboratories (NASDAQ: IPXL), Covis, Sun Pharma, Mayne, Endo (NASDAQ: ENDP), and Taro Pharma (NYSE: TARO).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Macy's (M), Sears (SHLD), Kohl's Corp. (KSS) Accused of Posting Fake 'Original' Prices - Bloomberg
- Venaxis (APPY) Changes Name to Bioptix; Will Trade Under Ticker 'BIOP'
- Lionsgate (LGF) Closes Starz (STRZA) Merger
Create E-mail Alert Related CategoriesCorporate News, ETFs, Hot Corp. News, Litigation, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!